Chicken Sandwich Proxy Battle Playing Out Over MSG Use
McDonald’s Corp (NYSE:MCD) is testing a new chicken sandwich across three states and the National Owners Association is…
Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 202…
– Settlement with Teva represents final outstanding LINZESS patent litigation – – The earliest licensed entry of any…
Neovasc Highlights Presentations Across Germany Featuring Co.’s Reducer Product
Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve…
Neurotrope Awarded $2.7M In Funding By National Institute Of Health To Support Phase 2 Alzheimer’s Study
Analysis to adjust for significant baseline imbalance in Severe Impairment Battery scores between treatment groups shows improvement in…
Akcea And Ionis Report Topline Phase 2 Results Of AKCEA-APOCIII-L Rx; Primary And Key Secondary Endpoints Were Met With ‘Significant Reduction’ In apoC-III And Triglyceride Levels
Favorable safety and tolerability were demonstrated in hypertriglyceridemia patients in the study Primary and key secondary endpoints were…
Baudax Bio Announces Feb. 20 PDUFA Date For Intravenous Meloxica
Baudax Bio, Inc. (NASDAQ:BXRX), a specialty pharmaceutical company focused on therapeutics for acute care settings, today announced that…
Genmab Highlights 2019 Net DARZALEX Sales By Johnson & Johnson Of $2.998B
Company Announcement Net trade sales of DARZALEX in 2019 totaled USD 2,998 million Genmab to receive milestone…
Moderna In Statement Says Its mRNA Vaccine Technology Could ‘ serve as a rapid and flexible platform that may be useful in responding to newly emerging viral threats, such as the novel coronavirus’; Says Working On Potential Vaccine Response To Emergen…
On the evening of January21, 2020, Moderna, Inc. provided a statement to a news outlet regarding its participation…
Axonics Announces FDA Approval Of Enhanced Neurostimulator Programmer
Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable…
EC Approves Roche’s Polivy for People with Previously Treated Aggressive Lymphoma
Roche (OTC:RHHBY) today announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in…